2m 2m 2m 2m 2m 2m 2m
CRYO-CELL INTL (CCEL)
NYSE
$4.47-$0.02 (-0.45%)
Price as of Oct 23, 2026 7:30 PM EDT- $36.2MMarket Cap
- 1.13%1-Year Change
- Medical Care FacilitiesIndustry
CRYO-CELL INTL (CCEL)
$4.47-$0.02 (-0.45%)
Annual
Quarterly
11/30/2025 | 11/30/2024 | 11/30/2023 | 11/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 31.4M -1.89% | 32.0M +2.05% | 31.3M +3.32% | 30.3M +5.03% | |
Cost of Revenue | 7.4M -7.19% | 7.9M -5.86% | 8.4M -3.98% | 8.8M -2.20% | |
Gross Profit | 24.0M -0.13% | 24.0M +4.96% | 22.9M +6.30% | 21.5M +8.29% | |
Sales and Marketing Expense | 18.2M -1.62% | 18.5M +8.21% | 17.1M +9.85% | 15.6M +6.53% | |
Research and Development Expense | -376,263 -69.72% | -1.2M +6.07% | -1.2M +204.44% | -384,789 +671.58% | |
Depreciation and Amortization Expense | 985,242 +42.00% | 693,847 -50.43% | 1.4M -6.62% | 1.5M +44.25% | |
Total Operating Expenses | 31.1M +9.04% | 28.5M -34.69% | 43.6M +65.88% | 26.3M +5.75% | |
Operating Profit | 482,394 -86.14% | 3.5M +128.29% | -12.3M -405.73% | 4.0M +0.53% | |
Interest Income | 0 +100.00% | -308,000 N/A | N/A N/A | N/A N/A | |
Interest Expense | -912,660 -51.06% | -1.9M +50.77% | -1.2M -18.73% | -1.5M +10.36% | |
Interest Income and Expense and Net | -912,660 -57.99% | -2.2M +75.67% | -1.2M -18.73% | -1.5M +10.36% | |
Total Nonoperating Income and Expense | -2.8M +316.99% | -676,163 -36.24% | -1.1M +50.31% | -705,519 -49.31% | |
Income before Taxes | -2.3M -183.35% | 2.8M +120.98% | -13.4M -502.67% | 3.3M +27.10% | |
Income Taxes | 92,232 -96.16% | 2.4M +162.51% | -3.8M -801.83% | 547,540 +3.76% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -2.4M -704.18% | 402,095 +104.22% | -9.5M -443.57% | 2.8M +33.02% | |
Net Income from Continuing Operations Applicable to Common | -2.3M -183.35% | 2.8M +120.98% | -13.4M -502.67% | 3.3M +27.10% | |
Basic EPS and Net Income | -0.30 -700.00% | 0.05 +104.39% | -1.14 -445.45% | 0.33 +26.92% | |
Diluted EPS and Net Income | -0.30 -700.00% | 0.05 +104.39% | -1.14 -445.45% | 0.33 +32.00% | |
Basic Weighted Average Shares | 8.1M -0.76% | 8.1M -2.52% | 8.3M -1.47% | 8.5M +4.03% | |
Diluted Weighted Average Shares | 8.1M -1.75% | 8.2M -1.54% | 8.3M -1.69% | 8.5M +1.46% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 319,031 -43.13% | 560,960 +38.14% | 406,067 -76.17% | 1.7M -79.38% | |
Short-Term Investments | 3.0M +1.43% | 2.9M +411.19% | 574,183 +3,158.70% | 17,620 -76.64% | |
Cash and Cash Equivalents and Short-Term Investments | 3.3M -5.72% | 3.5M +256.66% | 980,250 -43.06% | 1.7M -79.35% | |
Total Current Assets | 11.8M -6.34% | 12.6M +32.81% | 9.5M -1.64% | 9.6M -39.11% | |
Accumulated Depreciation | 6.6M +16.34% | 5.6M -30.62% | 8.1M +4.17% | 7.8M +3.79% | |
Property and Plant and Equipment and Net | 21.0M -3.93% | 21.9M +4.27% | 21.0M +54.35% | 13.6M +321.12% | |
Total Long-Term Assets | 28.9M -4.28% | 30.2M -1.76% | 30.8M -26.16% | 41.7M +0.06% | |
Total Assets | 61.7M -4.56% | 64.7M +5.65% | 61.2M -5.65% | 64.9M +6.97% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 2.5M -32.70% | 3.7M +165.81% | 1.4M -42.71% | 2.4M +27.67% | |
Total Current Liabilities | 19.8M -8.36% | 21.6M +3.53% | 20.9M +7.10% | 19.5M -7.56% | |
Total Long-Term Debt | 9.0M -1.52% | 9.2M -1.29% | 9.3M -1.58% | 9.5M +154.42% | |
Total Long-Term Liabilities | 60.5M +7.54% | 56.3M +9.55% | 51.4M +9.50% | 46.9M +32.56% | |
Total Liabilities | 80.3M +3.13% | 77.9M +7.81% | 72.3M +8.79% | 66.4M +17.59% | |
Retained Earnings | -38.4M +17.27% | -32.8M +5.19% | -31.2M +44.01% | -21.6M +29.29% | |
Total Stockholders Equity | -18.6M +40.78% | -13.2M +19.81% | -11.0M +623.69% | -1.5M -136.43% | |
Total Shares Outstanding | 8.1M -0.33% | 8.1M -2.47% | 8.3M -2.51% | 8.5M -0.66% | |
Cash Flow | |||||
Cash from Operating Activities | 5.5M -8.86% | 6.0M -32.61% | 8.9M +4.05% | 8.6M +8.16% | |
Capital Expenditures | 230,475 -90.41% | 2.4M -64.85% | 6.8M -43.80% | 12.2M +563.49% | |
Cash from Investing Activities | -975,332 -80.00% | -4.9M -40.12% | -8.1M -46.70% | -15.3M +119.81% | |
Dividends Paid | 3.2M +59.92% | 2.0M N/A | 0 -100.00% | 7.7M N/A | |
Cash from Financing Activities | -4.7M +384.64% | -979,118 -52.77% | -2.1M -1,501.91% | 147,862 +104.81% | |
Financials Ratio | |||||
Gross Margin | 76.49% +1.79% | 75.15% +2.86% | 73.07% +2.88% | 71.02% +3.11% | |
Operating Margin | 1.54% -85.87% | 10.88% +127.72% | -39.26% -395.91% | 13.27% -4.28% | |
Return on Assets | -3.84% -701.72% | 0.64% +104.23% | -15.10% -442.05% | 4.41% +13.21% | |
Return on Equity | 15.27% +560.37% | -3.32% -102.19% | 151.67% -27.21% | 208.38% -24.03% | |
Revenue Growth | -1.89% -192.04% | 2.05% -38.25% | 3.32% -33.96% | 5.03% +169.19% | |
Current Ratio | 0.59 +2.22% | 0.58 +28.27% | 0.45 -8.15% | 0.49 -34.13% | |
Cash Ratio | 0.02 -38.08% | 0.03 +33.33% | 0.02 -77.71% | 0.09 -77.68% | |
Debt-to-Equity Ratio | -0.62 -36.40% | -0.97 +0.50% | -0.97 -87.56% | -7.79 -680.79% | |
Debt-to-Assets Ratio | 0.19 -6.18% | 0.20 +13.97% | 0.17 -4.59% | 0.18 +97.73% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow